ScienceDaily (Jan. 6, 2009) — A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. The research indicates that obesity may contribute to the development of ovarian cancer through a hormonal mechanism.

Ovarian cancer is the most fatal of gynecologic malignancies, and has a 5-year survival rate of only 37 percent. While studies have linked excess body weight to higher risks of certain cancers, little is known about the relationship between body mass index and ovarian cancer risk.

To investigate this issue, Dr. Michael F. Leitzmann of the National Cancer Institute and colleagues studied 94,525 U.S. women aged 50 to 71 years over a period of seven years. The researchers documented 303 ovarian cancer cases during this time and noted that among women who had never taken hormones after menopause, obesity was associated with an almost 80 percent higher risk of ovarian cancer. In contrast, no link between body weight and ovarian cancer was evident for women who had ever used menopausal hormone therapy.

According to Dr. Leitzmann, these findings support the hypothesis that obesity may enhance ovarian cancer risk in part through its hormonal effects. Excess body mass in postmenopausal women leads to an increased production of estrogen, which in turn may stimulate the growth of ovarian cells and play a role in the development of ovarian cancer.

Among women with no family history of ovarian cancer, obesity and increased ovarian cancer risk were also linked in this study. However, women that did have a positive family history of ovarian cancer showed no association between body mass and ovarian cancer risk.

These latest findings provide important additional information related to women's risks of developing ovarian cancer. "The observed relations between obesity and ovarian cancer risk have relevance for public health programs aimed at reducing obesity in the population," the authors wrote.

Story Source:

Adapted from materials provided by American Cancer Society, via EurekAlert!, a service of AAAS.

Journal Reference:

1. Michael F. Leitzmann, Corinna Koebnick, Kim N. Danforth, Louise A. Brinton, Steven C. Moore, Albert R. Hollenbeck, Arthur Schatzkin, and James V. Lacey, Jr. Body mass index and risk of ovarian cancer. Cancer, Online: January 05, 2009; Print: February 15, 2009 DOI: 10.1002/cncr.24086

Related Stories

Hormone Therapy Use Associated With Increased Risk Of Ovarian Cancer (July 15, 2009) — Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the ...  > read more

Ovarian Cancer: Obese And Non-Obese Patients Have Same Overall Survival (Jan. 14, 2009) — A new study showed that when actual body weight was used in chemo dosing for epithelial ovarian cancer, the overall survival is 40 months for non-obese patients and 47 months for obese patients, not ...  > read more

Weight Gain Related To Postmenopausal Breast Cancer Risk (Oct. 23, 2007) — Women who gain weight throughout adulthood rather than maintaining a stable weight may have an increased risk for breast cancer, according to a new report. This finding was observed among women who ...  > read more

Birth Control Pill Gives Long-Lasting Protection Against Ovarian Cancer, Study Shows (Jan. 27, 2008) — The contraceptive pill gives women substantial and long-lasting protection against ovarian cancer, according to a new report. The researchers found that the protection against ovarian cancer lasted ...  > read more

Search ScienceDaily

Safer Scans for Pregnant Women